2 News & Press Releases found

Selfdiagnostics news

Selfdiagnostics SARS-CoV-2 IgM/IgG Antibody Assay Kit is a rapid, accurate and straightforward point-of-care test kit that qualitatively detects IgM and IgG antibodies against the virus that causes COVID-19.

The test detects specific SARS CoV2 IgG and IgM antibodies in the blood in response to a coronavirus infection.

The detection of antibodies can be used to identify those who have already had contact with the virus. IgG may remain elevated for up to several months and possibly years, which could help determine who has been exposed to the coronavirus, even if a person did not exhibit any symptoms of the COVID-19 disease.

Furthermore, the test can

Jul. 3, 2020

Selfdiagnostics began development of a rapid SARS-CoV-2 test which enables faster detection of coronavirus infection at a lower price.

The new rapid test will significantly increase testing capacity and deliver greater resource efficiency. The project has been awarded an EIT Health product development grant by the European Institute of Innovation and Technology. The rapid test provides a lab-in-your-pocket solution which guarantees mobile testing capability based on the PCR (polymerase chain reaction) technique. The test kit can be used by doctors, clinics, laboratories, pharmacist and nursing homes alike. „Our r

May. 11, 2020